DE3248678A1 - Neue bicyclische verbindungen und verfahren zu ihrer herstellung - Google Patents

Neue bicyclische verbindungen und verfahren zu ihrer herstellung

Info

Publication number
DE3248678A1
DE3248678A1 DE19823248678 DE3248678A DE3248678A1 DE 3248678 A1 DE3248678 A1 DE 3248678A1 DE 19823248678 DE19823248678 DE 19823248678 DE 3248678 A DE3248678 A DE 3248678A DE 3248678 A1 DE3248678 A1 DE 3248678A1
Authority
DE
Germany
Prior art keywords
dioxolan
oxo
group
methyl
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19823248678
Other languages
German (de)
English (en)
Inventor
Gábor Dipl.-Chem.-Ing. Dr. Doleschall
György Dr. Fekete
József Dipl.-Chem-Ing. Dr. Fetter
György Dr. Budapest Hajós
Kálmán Dipl.-Chem.-Ing. Dr. Harsányi
Gyula Dipl.-Chem.-Ing. Dr. Hornyák
Károly Dipl.-Chem. Dr. Lempert
József Dipl.-Chem.-Ing. Dr. Nyitrai
Gyula Dipl.-Chem-Ing. Dr. Budapest Simig
László Dr. Szporny
Károly Dipl.-Chem.-Ing. Dr. Szentendre Zauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of DE3248678A1 publication Critical patent/DE3248678A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19823248678 1981-12-30 1982-12-30 Neue bicyclische verbindungen und verfahren zu ihrer herstellung Withdrawn DE3248678A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU814017A HU185493B (en) 1981-12-30 1981-12-30 Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptene derivatives

Publications (1)

Publication Number Publication Date
DE3248678A1 true DE3248678A1 (de) 1983-07-07

Family

ID=10966528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823248678 Withdrawn DE3248678A1 (de) 1981-12-30 1982-12-30 Neue bicyclische verbindungen und verfahren zu ihrer herstellung

Country Status (18)

Country Link
JP (1) JPS58118588A (es)
AT (1) AT375944B (es)
AU (1) AU9197382A (es)
BE (1) BE895488A (es)
CA (1) CA1192202A (es)
DE (1) DE3248678A1 (es)
ES (1) ES518725A0 (es)
FI (1) FI824518L (es)
FR (1) FR2519002A1 (es)
GB (1) GB2112391B (es)
GR (1) GR78431B (es)
HU (1) HU185493B (es)
IT (1) IT1210971B (es)
LU (1) LU84564A1 (es)
NL (1) NL8205065A (es)
PL (1) PL239887A1 (es)
SE (1) SE8207480L (es)
ZA (1) ZA829600B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1198440A (en) * 1982-04-08 1985-12-24 Choung U. Kim Carbapenem antibiotics
JPS6028981A (ja) * 1983-07-27 1985-02-14 Shionogi & Co Ltd ジオキソラニルペネムカルボン酸誘導体
CA2315056A1 (en) * 1997-12-16 1999-06-24 Terutaka Hashizume Carbapenem derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5625110A (en) * 1978-12-18 1981-03-10 Bristol Myers Co Antibacterial
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
JPS57176982A (en) * 1981-04-24 1982-10-30 Shionogi & Co Ltd Dioxolanylazetidinone compound, its preparation and use

Also Published As

Publication number Publication date
FI824518A0 (fi) 1982-12-30
ES8405797A1 (es) 1984-06-16
AT375944B (de) 1984-09-25
FI824518L (fi) 1983-07-01
JPS58118588A (ja) 1983-07-14
AU9197382A (en) 1983-07-07
LU84564A1 (fr) 1984-10-22
CA1192202A (en) 1985-08-20
PL239887A1 (en) 1984-01-02
ZA829600B (en) 1983-10-26
SE8207480D0 (sv) 1982-12-29
ES518725A0 (es) 1984-06-16
GR78431B (es) 1984-09-27
FR2519002A1 (fr) 1983-07-01
ATA450982A (de) 1984-02-15
GB2112391A (en) 1983-07-20
IT1210971B (it) 1989-09-29
IT8225065A0 (it) 1982-12-30
HU185493B (en) 1985-02-28
NL8205065A (nl) 1983-07-18
GB2112391B (en) 1985-10-16
SE8207480L (sv) 1983-07-01
BE895488A (fr) 1983-06-28

Similar Documents

Publication Publication Date Title
DE19916108C1 (de) Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
CH634579A5 (en) Process for preparing cephem compounds
EP0126709A1 (de) Verfahren zur Herstellung von optisch aktiven Azetidinonen
DE69916030T2 (de) Verfahren zur herstellung optisch aktiver threo-3-amino-1,2-epoxyverbindungen
CH617440A5 (es)
DE3248678A1 (de) Neue bicyclische verbindungen und verfahren zu ihrer herstellung
DE2633561A1 (de) Azabicycloheptan-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
CH642968A5 (de) Cephalosporin-analoge und verfahren zu deren herstellung.
EP0000057A1 (de) Selektiv geschützte 4,6-Di-O-(aminoglycosyl)-1,3-diaminocyclitole
DE3026602C2 (es)
DE60032453T2 (de) Ein verfahren zur synthese von ritonavir
DE3248675A1 (de) Verfahren zur herstellung heterocyclischer essigsaeurederivate (ii)
DE19515976C1 (de) beta-Azidoethansulfonylazid, Verfahren zu seiner Herstellung und seine Verwendung in Verfahren zur Herstellung von Taurinamid und Taurolidin
CH621336A5 (es)
CH655315A5 (de) Verfahren zur herstellung einer aminolactoncarbonsaeure.
CH641448A5 (de) Verfahren zur herstellung von beta-lactamen.
DE2707404C3 (de) Verfahren zur Herstellung von 5,6-Dehydropenicillinen
DE2534601A1 (de) Verfahren zur herstellung von camptothecin-aehnlichen verbindungen
CH655926A5 (de) Heterocyclische essigsaeuren und verfahren zu ihrer herstellung.
EP0259268A1 (de) Verfahren zur Herstellung optisch aktiver Beta-Lactame
EP0101602B1 (de) In 6-Stellung unsubstituierte 7-Oxo-4-oxa-diazabicyclo-(3.2.0)-hept-2-en Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Zwischenprodukte zur Synthese von beta-Lactamantibiotika
DE3248677A1 (de) Verfahren zur herstellung bicyclischer verbindungen (ii)
DE3248676A1 (de) Neue bicyclische verbindungen und verfahren zu ihrer herstellung (i)
DE2639397A1 (de) 7-oxo-1,3-diazabicyclo eckige klammer auf 3.2.o eckige klammer zu heptan-2-carbonsaeure-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE2615621A1 (de) Beta-lactam-antibiotika und -zwischenprodukte sowie ihr herstellungsverfahren

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee